Changes to the website
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4882

Next 25
Website Changes
11/19/2019 Publication in Nature Communications Confirms DRD2 as Target of ONC201
11/18/2019 Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas.
11/18/2019 Another paid survey!
11/13/2019 Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published
10/27/2019 Musella Foundation Online Support Groups are moving!
10/26/2019 NYU Langone Health launches new molecular assay to identify patients with brain tumors
10/24/2019 GBM patient and Caregiver Survey
10/22/2019 Donate or request expensive medicines!
10/10/2019 Oncology Pioneer xCures Names Experts to Advisory Boards
10/10/2019 New Trial of Focused Ultrasound in Glioblastoma: Opening the Blood-Brain Barrier for Chemotherapy
10/10/2019 First-line treatment of ONC 201 in newly diagnosed DIPG pediatric patients is now open.
10/09/2019 Any Amazon users?
09/30/2019 Optune Open House
09/27/2019 Barriers to accrual and enrollment in brain tumor trials
09/25/2019 Medicenna Presents Promising Update from its MDNA55 Clinical Trial in Recurrent Glioblastoma at the Targeting Innate Immunity Congress
09/14/2019 DeAngelis named MSK physician-in-chief, chief medical officer
09/13/2019 Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer
09/11/2019 Frankly Speaking About Brain Tumors
09/11/2019 Publication Reports Clinical Efficacy of ONC201 in Expanded Access H3 K27M-mutant Glioma Patients
09/09/2019 Bristol-Myers Squibb`s Opdivo fails 3rd straight test in tough-to-treat brain cancer
09/09/2019 Novocure Announces 27 Presentations at the American Society for Radiation Oncology 2019 Annual Meeting
08/30/2019 Musella Foundation awards a pediatric brain tumor research grant!
08/15/2019 DelMar Pharmaceuticals Reports Updated Results on Twenty Patients from the Phase 2 Clinical Trial of VAL-083 as First-Line Treatment in Newly-Diagnosed MGMT-Unmethylated Glioblastoma MultiForme (GBM)
08/15/2019 Attend an Optune Open House

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557